pomalidomide-based triplets improve responses in relapsed/refractory multiple myeloma
Published 5 years ago • 143 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:16
triplet regimens with pomalidomide in patients with multiple myeloma
-
1:07
dr. sharma on pomalidomide in relapsed/refractory multiple myeloma
-
1:17
dr. jagannath on pomalidomide in relapsed or refractory multiple myeloma
-
6:07
ixazomib plus pomalidomide, dexamethasone in relapsed/refractory myeloma
-
1:08
dr. berenson on pomalidomide in relapsed/refractory multiple myeloma
-
4:30
triplet regimens for relapsed multiple myeloma
-
4:01
pomalidomide low-dose dex dara in relapsed and/or refractory multiple myeloma
-
2:20
icaria: isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
-
3:17
clinical rationale for pomalidomide in myeloma
-
2:22
dr. voorhees on pomalidomide/dexamethasone/ixazomib triplet in multiple myeloma
-
51:36
relapsed refractory multiple myeloma | current treatment options | options on the horizon
-
7:56
using pomalidomide in multiple myeloma
-
6:09
pomalidomide in multiple myeloma - video abstract id 115456
-
1:46
eloquent-2 study in patients with relapsed/refractory multiple myeloma
-
5:35
optimismm trial for refractory multiple myeloma
-
10:27
pomalidomide in refractory multiple myeloma
-
3:43
pomalidomide, cyclophosphamide, dex. superior to pomalidomide & dex. - relapsed & refractory myeloma
-
1:35
comparing results for 3-drug and 2-drug regimens in relapsed/refractory myeloma
-
25:25
icaho19 - multiple myeloma session: relapsed/refractory myeloma